Hunt RH - Search Results

1

Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.

Jenkins RT, Jones DB, Goodacre RL, Collins SM, Coates G, Hunt RH, Bienenstock J. Jenkins RT, et al. Among authors: hunt rh. Am J Gastroenterol. 1987 Nov;82(11):1159-64. Am J Gastroenterol. 1987. PMID: 3118697

2

Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.

Jenkins RT, Ramage JK, Jones DB, Collins SM, Goodacre RL, Hunt RH. Jenkins RT, et al. Among authors: hunt rh. Clin Invest Med. 1988 Apr;11(2):151-5. Clin Invest Med. 1988. PMID: 3135136

3

Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis.

Ramage JK, Stanisz A, Scicchitano R, Hunt RH, Perdue MH. Ramage JK, et al. Among authors: hunt rh. Gastroenterology. 1988 Jun;94(6):1368-75. Gastroenterology. 1988. PMID: 3129330

4

The effect of naloxone on lipid-induced pyloric motor response in humans.

Tougas G, Bovell KT, Collins SM, Dent J, Hunt RH. Tougas G, et al. Among authors: hunt rh. Gastroenterology. 1990 Oct;99(4):930-4. doi: 10.1016/0016-5085(90)90609-5. Gastroenterology. 1990. PMID: 2168331

5

14C-urea breath test for the detection of Helicobacter pylori.

Veldhuyzen van Zanten SJ, Tytgat KM, Hollingsworth J, Jalali S, Rshid FA, Bowen BM, Goldie J, Goodacre RL, Riddell RH, Hunt RH. Veldhuyzen van Zanten SJ, et al. Among authors: hunt rh. Am J Gastroenterol. 1990 Apr;85(4):399-403. Am J Gastroenterol. 1990. PMID: 2327381

6

Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis.

Veldhuyzen van Zanten SJ, Tytgat KM, Jalali S, Goodacre RL, Hunt RH. Veldhuyzen van Zanten SJ, et al. Among authors: hunt rh. J Clin Gastroenterol. 1989 Oct;11(5):496-501. doi: 10.1097/00004836-198910000-00003. J Clin Gastroenterol. 1989. PMID: 2677123 Review.

7

An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis.

Hogaboam CM, Muller MJ, Collins SM, Hunt RH. Hogaboam CM, et al. Among authors: hunt rh. Eur J Pharmacol. 1996 Aug 15;309(3):261-9. doi: 10.1016/0014-2999(96)00276-2. Eur J Pharmacol. 1996. PMID: 8874149

8

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.

Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Jones DB, et al. Among authors: hunt rh. Gut. 1987 Sep;28(9):1120-7. doi: 10.1136/gut.28.9.1120. Gut. 1987. PMID: 2890561 Free PMC article. Clinical Trial.

9

Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?

Veldhuyzen van Zanten SJ, Tytgat KM, Pollak PT, Goldie J, Goodacre RL, Riddell RH, Hunt RH. Veldhuyzen van Zanten SJ, et al. Among authors: hunt rh. J Clin Epidemiol. 1993 Mar;46(3):273-9. doi: 10.1016/0895-4356(93)90075-c. J Clin Epidemiol. 1993. PMID: 8455052

10

Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.

Jones DB, Howden CW, Burget DW, Silletti C, Hunt RH. Jones DB, et al. Among authors: hunt rh. Gut. 1988 Jul;29(7):890-3. doi: 10.1136/gut.29.7.890. Gut. 1988. PMID: 2969357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page